Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
BMC Vet Res ; 17(1): 383, 2021 Dec 11.
Article in English | MEDLINE | ID: mdl-34895249

ABSTRACT

BACKGROUND: Feline pancreatitis (FP) is an important health problem of cats. Its diagnostics is based on the combination of quantification of serum pancreatic lipase immunoreactivity (fPLI) and abdominal ultrasonography (AUS). These modalities allow for establishing highly specific diagnosis, however they are relatively expensive and time-consuming. On the other hand, a screening test of high sensitivity which would allow to rule out FP on the first visit without a considerable increase of costs would be clinically useful. To evaluate accuracy of nonspecific inflammatory biomarkers based on complete blood count (CBC) in diagnosing FP 73 client-owned cats with signs of lethargy and reduced appetite lasting for at least 2 days before presentation were enrolled in the cross-sectional study. They were examined with fPLI assay and AUS and classified as cats with very low risk of FP when fPLI ≤3.5 µg/L and AUS negative for FP, or as cats with increased risk of FP in the case of any other combination of results. Then, 7 various CBC measurements were measured in each cat and linked to the risk of FP using the multivariable logistic regression. RESULTS: Five CBC measurements turned out to be significantly associated with the risk of FP - total leukocyte count (WBC; crude odds ratio(ORcrude) = 12.2; CI 95%: 1.52, 98.5), total neutrophil count (ORcrude = 5.84; CI 95%: 1.22, 27.9), band neutrophil count (BNC; ORcrude = 6.67; CI 95%: 1.98, 22.4), neutrophil-to-lymphocyte ratio (ORcrude = 3.68; CI 95%: 1.25, 10.9), and eosinophil count (EC; ORcrude = 0.34; CI 95%: 0.12, 0.96). The model based on WBC, BNC, and EC proved to have at least fair diagnostic potential (area under ROC curve 82.7%; CI 95%: 72.8%, 92.5%). When WBC <  18 G/L, BNC <  0.27 G/L, and EC >  0.3 G/L was considered as a negative result, and any other combination as the positive result, the CBC model had high sensitivity (91.8%; CI 95%: 80.8%, 96.8%) at a relatively low specificity (58.3%; CI 95%: 38.8%, 75.5%). CONCLUSION: The combination of three CBC measurements is an immediately available and fairly accurate screening method for identification of lethargic and anorectic cats with increased risk of FP.


Subject(s)
Cat Diseases , Feeding and Eating Disorders , Lethargy , Pancreatitis , Animals , Blood Cell Count/veterinary , Cat Diseases/blood , Cat Diseases/diagnosis , Cats , Cross-Sectional Studies , Feeding and Eating Disorders/etiology , Feeding and Eating Disorders/veterinary , Lethargy/blood , Lethargy/etiology , Lethargy/veterinary , Pancreatitis/blood , Pancreatitis/complications , Pancreatitis/diagnosis , Pancreatitis/veterinary , Sensitivity and Specificity
2.
Lab Med ; 51(4): e38-e41, 2020 Jul 08.
Article in English | MEDLINE | ID: mdl-31833546

ABSTRACT

The pancreatic enzymes lipase and amylase serve important functions in digestion/absorption of fats and polysaccharides. Measurement of these enzymes is often used in the emergency department to rule out acute pancreatitis in patients with nonspecific abdominal pain. In acute pancreatitis, serial measurements of plasma lipase and amylase typically follow a predictable temporal pattern of rise-and-fall kinetics: lipase levels rise within 4 to 8 hours, crest at 2× to 50× the upper reference limit at 24 hours, and decline to normal concentrations in 7 to 14 days. In situations in which the duration and magnitude of pancreatic enzyme elevation are more transient, clinicians should consider alternative causes for enzyme elevation. In this case report, incidental discovery of elevated lipase in an African American baby girl who ingested oxycodone resulted in additional laboratory and radiological work-up. Stronger awareness of exogenous influences on gastrointestinal motility may have prevented the need for further testing in this patient.


Subject(s)
Analgesics, Opioid/poisoning , Lethargy/diagnosis , Lipase/blood , Neurotoxicity Syndromes/diagnosis , Oxycodone/poisoning , Amylases/blood , Amylases/urine , Female , Humans , Infant , Lethargy/blood , Lipase/urine , Neurotoxicity Syndromes/blood
3.
Clin Chim Acta ; 454: 46-8, 2016 Feb 15.
Article in English | MEDLINE | ID: mdl-26747959

ABSTRACT

BACKGROUND: To investigate and differentiate the causes of hyponatremia in an 8-y old boy. METHODS: An 8-y boy presented with headache, vomiting, and diplopia. Magnetic resonance imaging of the brain confirmed a mass in the pineal region. Pathology report demonstrated a mixed germ cell tumor with a yolk sac component. A multi-agent chemotherapy and radiation regimen was initiated. He developed hyponatremia, with sodium concentrations varying from 116 to 133 mEq/l. RESULTS: Serum levels of sodium, chloride, phosphorous, uric acid, and osmolality were low. Serum α-fetoprotein, ß-HCG, and lactate dehydrogenase were highly elevated. Urine sodium and osmolality were increased. CONCLUSIONS: These presentations suggest that the patient has cerebral salt-wasting syndrome caused by intracranial germ cell tumor. Recognition and differentiation of cerebral salt-wasting syndrome from other disorders are essential.


Subject(s)
Headache/complications , Hyponatremia/complications , Inappropriate ADH Syndrome/etiology , Lethargy/complications , Neoplasms, Germ Cell and Embryonal/complications , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Child , Diagnosis, Differential , Headache/blood , Headache/therapy , Humans , Hyponatremia/blood , Hyponatremia/therapy , Inappropriate ADH Syndrome/blood , Inappropriate ADH Syndrome/therapy , Lethargy/blood , Lethargy/therapy , Magnetic Resonance Imaging , Male , Neoplasms, Germ Cell and Embryonal/blood , Neoplasms, Germ Cell and Embryonal/therapy
4.
J Health Popul Nutr ; 32(2): 270-5, 2014 Jun.
Article in English | MEDLINE | ID: mdl-25076664

ABSTRACT

Hypocalcaemia is common in severely-malnourished children and is often associated with fatal outcome. There is very limited information on the clinical predicting factors of hypocalcaemia in hospitalized severely-malnourished under-five children. Our objective was to evaluate the prevalence, clinical predicting factors, and outcome of hypocalcaemia in such children. In this case-control study, all severely-malnourished under-five children (n=333) admitted to the Longer Stay Ward (LSW), High Dependency Unit (HDU), and Intensive Care Unit (ICU) of the Dhaka Hospital of icddr,b between April 2011 and April 2012, who also had their total serum calcium estimated, were enrolled. Those who presented with hypocalcaemia (serum calcium <2.12 mmol/L) constituted the cases (n=87), and those admitted without hypocalcaemia (n=246) constituted the control group in our analysis. The prevalence of hypocalcaemia among severely-malnourished under-five children was 26% (87/333). The fatality rate among cases was significantly higher than that in the controls (17% vs 5%; p < 0.001). Using logistic regression analysis, after adjusting for potential confounders, such as vomiting, abdominal distension, and diastolic hypotension, we identified acute watery diarrhoea (AWD) (OR 2.19, 95% CI 1.08-4.43, p = 0.030), convulsion on admission (OR 21.86, 95% CI 2.57-185.86, p = 0.005), and lethargy (OR 2.70, 95% CI 1.633-5.46, p = 0.006) as independent predictors of hypocalcaemia in severely-malnourished children. It is concluded, severely-malnourished children presenting with hypocalcaemia have an increased risk of death than those without hypocalcaemia. AWD, convulsion, and lethargy assessed on admission to hospital are the clinical predictors of hypocalcaemia in such children. Presence of these features in hospitalized children with severe acute malnutrition (SAM) should alert clinicians about the possibility of hypocalcaemia and may help undertake potential preventive measures, such as calcium supplementation, in addition to other aspects of management of such children, especially in the resource-poor settings.


Subject(s)
Hospital Mortality , Hospitals, Urban , Hypocalcemia/epidemiology , Hypocalcemia/therapy , Infant Nutrition Disorders/epidemiology , Infant Nutrition Disorders/therapy , Anti-Bacterial Agents/therapeutic use , Bangladesh/epidemiology , Case-Control Studies , Comorbidity , Diarrhea, Infantile/blood , Diarrhea, Infantile/epidemiology , Diarrhea, Infantile/therapy , Female , Fluid Therapy/methods , Humans , Hypocalcemia/blood , Infant , Infant Nutrition Disorders/blood , Lethargy/blood , Lethargy/epidemiology , Lethargy/therapy , Male , Nutritional Support/methods , Odds Ratio , Oxygen/administration & dosage , Prevalence , Risk Factors , Seizures/blood , Seizures/epidemiology , Seizures/therapy , Severity of Illness Index , Treatment Outcome , Urban Population/statistics & numerical data
6.
Eur J Obstet Gynecol Reprod Biol ; 159(1): 53-6, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21752530

ABSTRACT

OBJECTIVE: Phenobarbital crosses the placenta quickly, and the balance between maternal and fetal blood is achieved in a few minutes. Data on the clinical outcomes of infants born to mothers under phenobarbital treatment during pregnancy show that they are at risk of adverse events, such as sedation and abstinence syndrome. The aim of this study was to analyse the correlation between serum levels of phenobarbital and clinical features of neonates. STUDY DESIGN: Twenty-three infants born between 2001 and 2008 were studied. Maternal, neonatal and pharmacological variables were considered. RESULTS: Eleven infants displayed symptoms related to phenobarbital. Withdrawal syndrome was seen in seven infants and sedation syndrome was seen in four infants. One infant had severe cardiorespiratory depression at birth. None of the infants had severe neonatal abstinence syndrome. No statistically significant differences were found between symptomatic and asymptomatic infants. At birth, the mean serum level of phenobarbital of the 23 infants was 15.4 [standard deviation (SD) 6.2] µg/ml. A peak (16.1 µg/ml, SD 5.5) was seen on Day 3, followed by a gradual decrease to non-therapeutic levels (<10 µg/ml) by Day 8 (9.3 µg/ml, SD 1.0). Phenobarbital levels were higher in symptomatic infants than asymptomatic infants, although the difference was not statistically significant. CONCLUSIONS: Serum levels of phenobarbital remained in the therapeutic range for both mothers and infants, and reduced gradually in infants. However, some infants displayed symptoms related to phenobarbital. As such, a clinical pharmacological surveillance protocol is necessary.


Subject(s)
Anticonvulsants/adverse effects , Anticonvulsants/blood , Epilepsy/drug therapy , Neonatal Abstinence Syndrome/blood , Phenobarbital/adverse effects , Phenobarbital/blood , Pregnancy Complications/drug therapy , Adult , Anticonvulsants/pharmacokinetics , Anticonvulsants/therapeutic use , Cohort Studies , Female , Hospitals, University , Humans , Infant, Newborn , Lethargy/blood , Lethargy/chemically induced , Lethargy/physiopathology , Male , Maternal-Fetal Exchange , Neonatal Abstinence Syndrome/physiopathology , Phenobarbital/pharmacokinetics , Phenobarbital/therapeutic use , Postpartum Period/blood , Pregnancy , Respiratory Distress Syndrome, Newborn/blood , Respiratory Distress Syndrome, Newborn/chemically induced , Respiratory Distress Syndrome, Newborn/physiopathology , Retrospective Studies , Severity of Illness Index , Young Adult
8.
Pediatr Emerg Care ; 25(3): 170-3, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19287273

ABSTRACT

BACKGROUND: Amitriptyline is one of the major tricyclic antidepressants, and the data on amitriptyline poisoning in children are limited. OBJECTIVES: To present our experiences with amitriptyline poisoning in children, particularly with regard to its effects on electrocardiogram (ECG) and relation with clinical status. METHODS: Clinical, laboratory, and electrocardiographic findings in 52 children admitted with amitriptyline poisoning were reviewed. Patients were divided into 2 groups according to age, as 6 years or younger (group A) and older than 6 years (group B). RESULTS: Mean age was 4.6 +/- 3.0 years. Thirty-one patients were male, and 41 were 6 years or younger. Ingested amitriptyline dose was known in 23 patients (range, 2.3 mg/kg-27 mg/kg). The most frequent findings were lethargy (76.9%), sinus tachycardia (57.7%), and coma (48.1%). Four patients had a history of convulsion. The most common laboratory abnormalities were hyponatremia (26.9%) and leukocytosis (25%). Elevated transaminase levels were observed in 4 patients. In ECG, 11 (22.4%) patients had QTc prolongation and in 4 (8.2%) of them, it was significant. In 4 patients (8.2%), the QRS duration was 100 ms or longer and in 15 patients, the R wave in aVR was 3 mm or longer. The frequencies of clinical, laboratory, and electrocardiographic findings were similar between the 2 age groups (P > 0.05). No clinically apparent arrhythmias were observed. The positive predictive value of a widened QRS was 100% in terms of coma. None of the patients with an R wave in aVR of less than 3 mm developed convulsion; thus, the negative predictive value of an R wave in aVR of 3 mm or longer was 100% in terms of convulsion. CONCLUSIONS: Amitriptyline poisoning may result in severe toxicity. Frequencies of clinical, laboratory, and ECG findings were similar in the 2 age groups. Amitriptyline overdose results in some ECG changes that can possibly help to predict the results of poisoning. Absence of an R wave in aVR of 3 mm or longer predicts seizures with a high negative predictive value, and a QRS duration of 100 or longer ms predicts coma with a high positive predictive value.


Subject(s)
Amitriptyline/poisoning , Antidepressive Agents, Tricyclic/poisoning , Electrocardiography, Ambulatory/drug effects , Lethargy/chemically induced , Leukocytosis/chemically induced , Sodium/blood , Tachycardia, Sinus/chemically induced , Adolescent , Child , Child, Preschool , Drug Overdose , Female , Follow-Up Studies , Humans , Infant , Lethargy/blood , Lethargy/physiopathology , Leukocytosis/blood , Leukocytosis/physiopathology , Male , Prognosis , Retrospective Studies , Status Epilepticus/blood , Status Epilepticus/chemically induced , Status Epilepticus/physiopathology , Tachycardia, Sinus/blood , Tachycardia, Sinus/physiopathology
10.
South Med J ; 100(2): 212-4, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17330696

ABSTRACT

Oxycodone and oxycodone-containing analgesics are often used for the relief of pain. In the presence of renal dysfunction, the half-life of oxycodone and metabolites can be prolonged. We describe the case of a 41-year-old chronic hemodialysis patient who received multiple doses of oxycodone/acetaminophen resulting in accumulation of the medication and consequent lethargy, hypotension and respiratory depression. These adverse effects were reversed with multiple bolus doses of naloxone, followed by a continuous infusion administered for 45 hours. Utilizing the Naranjo probability scale, the patient had a "probable" adverse drug reaction to the oxycodone. Oxycodone should be used with caution in patients with chronic renal failure.


Subject(s)
Analgesics, Opioid/pharmacokinetics , Kidney Failure, Chronic/therapy , Oxycodone/pharmacokinetics , Renal Dialysis , Adult , Analgesics, Opioid/adverse effects , Follow-Up Studies , Humans , Hypotension/blood , Hypotension/chemically induced , Kidney Failure, Chronic/blood , Lethargy/blood , Lethargy/chemically induced , Male , Oxycodone/adverse effects , Respiratory Insufficiency/blood , Respiratory Insufficiency/chemically induced
SELECTION OF CITATIONS
SEARCH DETAIL
...